Sunnyvale, CA, United States of America

Waheed M Roomi

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Santa Clara, CA (US) (2005)
  • Sunnyvale, CA (US) (2006 - 2021)

Company Filing History:


Years Active: 2005-2021

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations in Therapeutics: The Contributions of Waheed M Roomi

Introduction: Waheed M Roomi is a prominent inventor based in Sunnyvale, California, who has made significant strides in the medical field through his innovative approaches to therapies involving matrix metalloproteinases. With six patents to his name, his work focuses primarily on developing oligopeptides and their applications in combating various diseases.

Latest Patents: Among his notable inventions, Roomi's latest patents include the identification and therapeutic use of matrix metalloproteinase oligopeptides. These oligopeptides, specifically SEQ ID NO: 7, 11, 12, 18, and 19, demonstrate extraordinary potential when bound to antibodies, eliciting a robust immune response in mammalian subjects. This method serves as a powerful therapeutic intervention against diseases linked to matrix metalloproteinases. Moreover, his patents reveal the use of these oligopeptides and their peptidomimetics for creating antibodies that aid in diagnostics and treatment across various medical conditions. In particular, his research shows that suppression of matrix metalloproteinase activity can hinder tumor growth during cancer progression. Encouraging results were observed when MMP oligopeptides were used as vaccines for treating murine melanoma, resulting in a significant reduction in tumor size and weight among immunized subjects.

Career Highlights: Roomi has amassed a wealth of knowledge and experience throughout his career, significantly impacting the field of therapeutic inventions. His inventive contributions have not only advanced medical technology but have also provided new avenues for disease intervention.

Collaborations: Throughout his career, Roomi has collaborated with esteemed professionals, including Aleksandra Niedzwiecki and Matthias W Rath. His associations with notable entities have fostered innovative solutions and fostered the development of impactful therapeutic methodologies.

Conclusion: Waheed M Roomi's contributions to the landscape of medical innovation underscore the vital role that inventors play in addressing urgent health challenges. His pioneering work involving matrix metalloproteinase oligopeptides holds promise for enhancing therapeutic approaches and improving patient outcomes in the future. With continued research and collaboration, his inventions could lead to groundbreaking advancements in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…